Cargando…

Plasma microRNA biomarkers for detection of mild cognitive impairment

Early stages of many neurodegenerative diseases, such as Alzheimer's disease, vascular and frontotemporal dementia, and Parkinson's disease, are frequently associated with Mild Cognitive Impairment (MCI). A minimally invasive screening test for early detection of MCI may be used to select...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheinerman, Kira S., Tsivinsky, Vladimir G., Crawford, Fiona, Mullan, Michael J., Abdullah, Laila, Umansky, Samuil R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492224/ https://www.ncbi.nlm.nih.gov/pubmed/23001356

Ejemplares similares

Plasma microRNA biomarkers for detection of mild cognitive impairment: Biomarker Validation Study
por: Sheinerman, Kira S., et al.
Publicado: (2013)

Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome
por: Sheinerman, Kira, et al.
Publicado: (2019)

Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study
por: Sheinerman, Kira S, et al.
Publicado: (2013)

Age- and sex-dependent changes in levels of circulating brain-enriched microRNAs during normal aging
por: Sheinerman, Kira, et al.
Publicado: (2018)

Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
por: Sheinerman, Kira S., et al.
Publicado: (2013)

Early detection of neurodegenerative diseases: Circulating brain-enriched microRNA
por: Sheinerman, Kira S., et al.
Publicado: (2013)

Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment
por: Kunwar, Arzu, et al.
Publicado: (2023)

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
por: Sheinerman, Kira S., et al.
Publicado: (2017)

Aging and aging-associated diseases: a microRNA-based endocrine regulation hypothesis
por: Umansky, Samuil
Publicado: (2018)

Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis
por: Kayano, Mitsunori, et al.
Publicado: (2016)

Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
por: Salama, Iman I., et al.
Publicado: (2020)

Correction: Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
por: Salama, Iman I., et al.
Publicado: (2020)

Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Elevated Plasma microRNA-206 Levels Predict Cognitive Decline and Progression to Dementia from Mild Cognitive Impairment
por: Kenny, Aidan, et al.
Publicado: (2019)

Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment
por: Weinberg, Rebecca B., et al.
Publicado: (2015)

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
por: De Felice, Bruna, et al.
Publicado: (2020)

Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment
por: Wang, Tao, et al.
Publicado: (2016)

APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease
por: Abdullah, Laila, et al.
Publicado: (2017)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Evaluation of long-term COVID-19
por: Kiefer, Michael C., et al.
Publicado: (2021)

MicroRNA: A Linking between Astrocyte Dysfunction, Mild Cognitive Impairment, and Neurodegenerative Diseases
por: Ramírez, Angelica E., et al.
Publicado: (2022)

Proteasome Activity in the Plasma as a Novel Biomarker in Mild Cognitive Impairment with Chronic Tinnitus
por: Yun, Yejin, et al.
Publicado: (2020)

Risk Factors Associated with Mild Cognitive Impairment among Apparently Healthy People and the Role of MicroRNAs
por: Salama, Iman I., et al.
Publicado: (2019)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Converging and Differential Brain Phospholipid Dysregulation in the Pathogenesis of Repetitive Mild Traumatic Brain Injury and Alzheimer’s Disease
por: Ojo, Joseph O., et al.
Publicado: (2019)

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
por: Giacomucci, Giulia, et al.
Publicado: (2022)

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms
por: Nkiliza, Aurore, et al.
Publicado: (2021)

The Effect of Deep Micro Vibrotactile Stimulation on Cognitive Function of Mild Cognitive Impairment and Mild Dementia
por: Kodama, Ayuto, et al.
Publicado: (2022)

Disruption in Brain Phospholipid Content in a Humanized Tau Transgenic Model Following Repetitive Mild Traumatic Brain Injury
por: Ojo, Joseph O., et al.
Publicado: (2018)

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
por: Giau, Vo Van, et al.
Publicado: (2019)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Mutual Interaction of Clinical Factors and Specific microRNAs to Predict Mild Cognitive Impairment in Patients Receiving Hemodialysis
por: Chen, Jin-Bor, et al.
Publicado: (2020)

Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke
por: Shang, Jingwei, et al.
Publicado: (2018)

Profile of Cognitive Complaints in Vascular Mild Cognitive Impairment and Mild Cognitive Impairment
por: Gu, Jenny, et al.
Publicado: (2013)

Regulatory microRNAs and vascular cognitive impairment and dementia
por: Zhang, Jing, et al.
Publicado: (2020)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Characteristics of TCM Constitution and Related Biomarkers for Mild Cognitive Impairment
por: Deng, Xiangming, et al.
Publicado: (2021)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review
por: Ding, Zihan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h61ul622st4mtc80ehi5sob4ph